This approach to initial staging made it possible for about 17% of patients to safely skip TURBT, said Nicholas D. James, PhD, of the Institute of Cancer Research in London, and colleagues.

Participants with suspected new BC were randomly assigned 1:1 to TURBT-staged or mpMRI-staged care, with minimization factors of sex, age, and clinician visual assessment of stage. Blinding was ...

Discover how AI-based assays offer a promising approach to tailor treatment for high-risk non-muscle-invasive bladder cancer.

A propensity-score matched cohort study found a significantly reduced risk of recurrence of bladder cancer in patients who ...

Investigators employed artificial intelligence to characterize tissue samples of high-risk NMIBC that were likely to recur or progress after treatment with intravesical bacillus Calmette-Guérin (BCG).

Eddie Jordan, the Formula 1 legend, died on Thursday in Cape Town, South Africa following a journey with bladder cancer, ...

NANTONG, China and MELBOURNE, Australia I March 24, 2025 I Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA ...

Aura Biosciences (AURA) announced data from a completed Phase 1 window of opportunity trial of bel-sar in patients with NMIBC. These data were ...

The standard first-line treatment is transurethral resection of the bladder tumor (TURBT) followed by intravesical BCG immunotherapy. However, a significant proportion of patients experience ...

The completed Phase 1 trial was conducted over a 56-day period, with patients receiving treatment 7 to 12 days before the standard transurethral resection of bladder tumor (TURBT) procedure.

models to identify adverse features on digitized images of tissue samples obtained during transurethral resection of bladder tumor (TURBT) prior to BCG induction. The CHAI platform examined 600 ...